Trials / Completed
CompletedNCT01520324
Neoplasia Detection With Methylene Blue MMX Tablets in Patients With UC Undergoing Colonoscopy
Intraepithelial Neoplasia Detection Rate After Single Oral Dose of Methylene Blue MMX Modified Release Tablets Administered to Patients With Long Standing Ulcerative Colitis Undergoing Colonoscopy.
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 53 (actual)
- Sponsor
- Cosmo Technologies Ltd · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Evaluation of the intraepithelial neoplasia detection rate in patients with long standing ulcerative colitis undergoing mucosal staining with oral methylene blue MMX tablets prior to colonoscopy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | oral delivery mucosal stain | 200mg methylene blue MMX tablet taken prior to colonoscopy |
Timeline
- Start date
- 2012-01-01
- Primary completion
- 2012-07-01
- Completion
- 2012-07-01
- First posted
- 2012-01-27
- Last updated
- 2019-02-08
- Results posted
- 2019-02-08
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT01520324. Inclusion in this directory is not an endorsement.